# 21 CFR Part 1308—Schedules of controlled substances

21 CFR Part 1308—Schedules of controlled substances, “Schedules of controlled substances”, is a CFR part of [21 CFR Chapter II—DRUG ENFORCEMENT ADMINISTRATION, DEPARTMENT OF JUSTICE](https://ontology.bommaritollc.com/id/01a0f094-b774-767f-a5ef-7a8714cf1bef); it is made under 4 laws; in force.

IRI: <https://ontology.bommaritollc.com/id/01a0f094-b8cd-732f-a957-b60db5d17f2b>

Within: [Title 21—Food and Drugs](https://ontology.bommaritollc.com/id/01a0f094-b437-7426-9a1d-f0a9f3d3e1aa) › [21 CFR Chapter II—DRUG ENFORCEMENT ADMINISTRATION, DEPARTMENT OF JUSTICE](https://ontology.bommaritollc.com/id/01a0f094-b774-767f-a5ef-7a8714cf1bef)

Type: [schema:Legislation](https://schema.org/Legislation)

- `adms:identifier`: [cfr-part 21 CFR Part 1308](https://ontology.bommaritollc.com/id/01a0f094-b8ce-77a4-afa7-d1c750d2e72c)
- **authority note** (`bcleg:authorityNote`): 21 U.S.C. 811, 812, 871(b), 956(b), unless otherwise noted.
- `eli:based_on`:
  - [21 U.S.C. 811 Authority and criteria for classification of substances](https://ontology.bommaritollc.com/id/01a0f06c-cead-7134-802a-d04647237fb8)
  - [21 U.S.C. 812 Schedules of controlled substances](https://ontology.bommaritollc.com/id/01a0f06c-ceaf-73a8-b0b7-8bea12e9b461)
  - [21 U.S.C. 871 Attorney General](https://ontology.bommaritollc.com/id/01a0f06c-ceec-727f-840f-f9b7f99bf8e1)
  - [21 U.S.C. 956 Exemption authority](https://ontology.bommaritollc.com/id/01a0f06c-cf15-776a-9e7c-bc5040d9bc3c)
- `prov:wasDerivedFrom`:
  - [evidence from https://www.govinfo.gov/app/details/CFR-2025-title21-vol9](https://ontology.bommaritollc.com/id/01a0f094-b8cd-732f-a957-b60c872dfb13)
  - [evidence from https://www.govinfo.gov/app/details/](https://ontology.bommaritollc.com/id/01a0f094-da49-7001-a0cc-e8fad3c0f644)
  - [evidence from https://www.govinfo.gov/app/details/](https://ontology.bommaritollc.com/id/01a0f0cf-7f0f-7450-b9b4-5c952c97cf1c)
  - [evidence from https://www.govinfo.gov/link/cfr/21/1308?year=mostrecent&link-type=details](https://ontology.bommaritollc.com/id/01a10f16-3edc-76ee-ab8c-93ba3eaa9e59)
- `schema:isPartOf`: [21 CFR Chapter II—DRUG ENFORCEMENT ADMINISTRATION, DEPARTMENT OF JUSTICE](https://ontology.bommaritollc.com/id/01a0f094-b774-767f-a5ef-7a8714cf1bef)
- `schema:legislationIdentifier`: 21 CFR Part 1308
- `schema:legislationJurisdiction`: [United States](https://ontology.bommaritollc.com/id/01a0ed8e-f797-7004-b7f5-bec2695977c0)
- `schema:legislationLegalForce`: [schema:InForce](https://schema.org/InForce)
- `schema:legislationType`: [CFR part](https://ontology.bommaritollc.com/vocab/leg/cfrPart)
- `schema:name`: Schedules of controlled substances
- `schema:url`: [https://www.govinfo.gov/link/cfr/21/1308?year=mostrecent&link-type=details](https://www.govinfo.gov/link/cfr/21/1308?year=mostrecent&link-type=details)
- `skos:prefLabel`: 21 CFR Part 1308—Schedules of controlled substances
- **source note** (`bcleg:sourceNote`): 38 FR 8254, Mar. 30, 1973, unless otherwise noted. Redesignated at 38 FR 26609, Sept. 24, 1973.

## Elsewhere

- [Official page](https://www.govinfo.gov/link/cfr/21/1308?year=mostrecent&link-type=details) (www.govinfo.gov)
- [Source](https://www.govinfo.gov/app/details/CFR-2025-title21-vol9) (www.govinfo.gov)
- [Source](https://www.govinfo.gov/app/details/) (www.govinfo.gov)

## Pointing here

- Cited by (60; `eli:cites`):
  - [21 CFR 1300.01 Definitions relating to controlled substances.](https://ontology.bommaritollc.com/id/01a0f094-d612-7577-9fae-9aaa9e535a16)
  - [21 CFR 1300.02 Definitions relating to listed chemicals.](https://ontology.bommaritollc.com/id/01a0f094-d613-73f0-b086-02d0b59bb227)
  - [21 CFR 1301.13 Application for registration; time for application; expiration date; registration for independent activities; application forms, fees, contents and signature; coincident activities.](https://ontology.bommaritollc.com/id/01a0f094-d61a-7667-acf6-4cc741d6d5f1)
  - [21 CFR 1301.35 Certificate of registration; denial of registration.](https://ontology.bommaritollc.com/id/01a0f094-d629-70e9-890a-97090bf0856a)
  - [21 CFR 1303.15 Procurement quotas.](https://ontology.bommaritollc.com/id/01a0f094-d645-7256-8266-978a9a31c65d)
  - [21 CFR 1303.22 Procedure for applying for individual manufacturing quotas.](https://ontology.bommaritollc.com/id/01a0f094-d648-743a-aab1-3c264c8122f5)
  - [21 CFR 1312.12 Application for import permit; return information.](https://ontology.bommaritollc.com/id/01a0f094-d71a-7616-8e6a-ada5dc702863)
  - [21 CFR 1312.18 Import declaration.](https://ontology.bommaritollc.com/id/01a0f094-d71e-700c-b42f-63638bc8598e)
  - [21 CFR 1312.22 Application for export or reexport permit; return information.](https://ontology.bommaritollc.com/id/01a0f094-d721-744e-be07-d36d301291c9)
  - [21 CFR 1312.27 Export/reexport declaration.](https://ontology.bommaritollc.com/id/01a0f094-d724-7278-b537-181c4cc381a7)
  - [21 CFR 312.58 Inspection of sponsor's records and reports.](https://ontology.bommaritollc.com/id/01a0f094-c4a3-753c-adee-67bebff2267a)
  - [25 CFR 11.452 Possession of a controlled substance.](https://ontology.bommaritollc.com/id/01a0f098-922b-7570-87fa-48fcc8dc3013)
  - [31 CFR 605.1 Conduct on Bureau of Engraving and Printing property.](https://ontology.bommaritollc.com/id/01a0f09f-c003-7206-8da1-8cd65304368b)
  - [32 CFR 273.3 Definitions.](https://ontology.bommaritollc.com/id/01a0f0a1-34c2-769d-9db4-b4a0a63045c8)
  - [33 CFR 95.010 Definition of terms as used in this part.](https://ontology.bommaritollc.com/id/01a0f0a2-c5b5-74ad-b95e-741ed7af97a0)
  - [38 CFR 1.515 Disclosure of information to participate in state prescription drug monitoring programs.](https://ontology.bommaritollc.com/id/01a0f0ab-877f-735e-87bd-98afb52315ea)
  - [40 CFR 266.506 Conditional exemption for hazardous waste pharmaceuticals that are also controlled substances and household waste pharmaceuticals collected by an authorized collector.](https://ontology.bommaritollc.com/id/01a0f0b0-385e-76ac-8b3f-7dbea305f7c7)
  - [41 CFR 102-40.30 What definitions apply to this part?](https://ontology.bommaritollc.com/id/01a0f0b2-6398-7425-8b91-2bbe7690b953)
  - [49 CFR 219.5 Definitions.](https://ontology.bommaritollc.com/id/01a0ee02-650c-7601-ab4a-a23d3a36d235)
  - [49 CFR 350.207 MCSAP administration: Conditions to qualify for funds.](https://ontology.bommaritollc.com/id/01a0ee02-6b3b-73ae-a1e2-bc6a437fa100)
  - [49 CFR 382.213 Controlled substance use.](https://ontology.bommaritollc.com/id/01a0ee02-6c8d-756f-aa28-5c271f2ff303)
  - [49 CFR 383.5 Definitions.](https://ontology.bommaritollc.com/id/01a0ee02-6cac-734e-aa2d-2d3bfd7c50fb)
  - [49 CFR 391.41 Physical qualifications for drivers.](https://ontology.bommaritollc.com/id/01a0ee02-6e12-7451-ab7c-c964b1574a55)
  - [49 U.S.C. 31102 Motor carrier safety assistance program](https://ontology.bommaritollc.com/id/01a0edf4-84bb-75f2-b3f7-d8d601c884db)
  - [7 CFR 1955.105 Real property affected (CONACT).](https://ontology.bommaritollc.com/id/01a0ee02-4f74-70f5-a970-02ff1d62eadd)
  - [7 CFR 1962.30 Subordination and waiver of liens on chattel security.](https://ontology.bommaritollc.com/id/01a0ee02-4ffc-7104-8030-a9aa096ba67f)
  - [7 CFR 1962.34 Transfer of chattel security and EO property and assumption of debts.](https://ontology.bommaritollc.com/id/01a0ee02-4ffe-700e-a31b-9a8d933ee4a6)
  - [7 CFR 718.2 Definitions.](https://ontology.bommaritollc.com/id/01a0ee02-2dad-708f-acd1-1812968a6c26)
  - [7 CFR 772.6 Subordination of security.](https://ontology.bommaritollc.com/id/01a0ee02-3076-706a-878f-f43cc8e90e7e)
  - [FR Doc. 2023-06893: Schedules of Controlled Substances: Temporary Placement of MDMB-4en-PINACA, 4F-MDMB-BUTICA, ADB-4en-PINACA, CUMYL-PEGACLONE, 5F-EDMB-PICA, and MMB-FUBICA in Schedule I](https://ontology.bommaritollc.com/id/01a110b2-3f13-7130-a101-933ae6d667ff)
  - [FR Doc. 2023-07576: Schedules of Controlled Substances: Placement of Nine Specific Fentanyl-Related Substances in Schedule I](https://ontology.bommaritollc.com/id/01a110b2-4930-729a-9383-dfb7a9a27a0e)
  - [FR Doc. 2023-07578: Definition of “Cannabimimetic Agents” and Assignment of an Administration Controlled Substances Code Number for All “Cannabimimetic Agents”](https://ontology.bommaritollc.com/id/01a110b2-492b-763a-9061-ff5835a60417)
  - [FR Doc. 2023-20439: Schedules of Controlled Substances: Placement of Ethylphenidate in Schedule I](https://ontology.bommaritollc.com/id/01a110b2-ccee-71a9-9bb7-15fc4bf4468a)
  - [FR Doc. 2023-23379: Schedules of Controlled Substances: Temporary Placement of N-Desethyl Isotonitazene and N-Piperidinyl Etonitazene in Schedule I](https://ontology.bommaritollc.com/id/01a110b2-e66b-715c-a63f-8c5132ab0252)
  - [FR Doc. 2023-27289: Schedules of Controlled Substances: Placement of 2,5-dimethoxy-4-iodoamphetamine (DOI) and 2,5-dimethoxy-4-chloroamphetamine (DOC) in Schedule I](https://ontology.bommaritollc.com/id/01a110b3-0590-74b2-bb0d-3301f1731680)
  - [FR Doc. 2024-07473: Announcement of Hearing: Schedules of Controlled Substances: Placement of 2,5-dimethoxy-4-iodoamphetamine (DOI) and 2,5-dimethoxy-4-chloroamphetamine (DOC) inSchedule I](https://ontology.bommaritollc.com/id/01a110b3-4a1c-720b-9a40-5724328d65a5)
  - [FR Doc. 2024-07694: Schedules of Controlled Substances: Placement of Butonitazene, Flunitazene, and Metodesnitazene Substances in Schedule I](https://ontology.bommaritollc.com/id/01a110b3-4bb2-708e-8e11-d796c478c250)
  - [FR Doc. 2024-11137: Schedules of Controlled Substances: Rescheduling of Marijuana](https://ontology.bommaritollc.com/id/01a110b3-63da-75ed-97c2-c733a561259c)
  - [FR Doc. 2024-12504: Announcement of Stayed Hearing: Schedules of Controlled Substances: Placement of 2,5-dimethoxy-4-iodoamphetamine (DOI) and 2,5-dimethoxy-4-chloroamphetamine (DOC) in Schedule I](https://ontology.bommaritollc.com/id/01a110b3-6dfa-7621-844a-df924a7613f7)
  - [FR Doc. 2024-21058: Schedules of Controlled Substances: Temporary Placement of N-Pyrrolidino Metonitazene and N-Pyrrolidino Protonitazene in Schedule I](https://ontology.bommaritollc.com/id/01a110b3-a728-707b-abe8-d2a4d4d087eb)
  - [FR Doc. 2024-30359: Schedules of Controlled Substances: Placement of 4-Chloromethcathinone in Schedule I](https://ontology.bommaritollc.com/id/01a110b3-e639-754e-bd67-216a13369f14)
  - [FR Doc. 2024-30798: Schedules of Controlled Substances: Placement of Seven Specific Fentanyl-Related Substances in Schedule I](https://ontology.bommaritollc.com/id/01a110b3-e63b-72c9-92ed-a49cf6b3526e)
  - [FR Doc. 2025-09988: Schedules of Controlled Substances: Placement of 4-Fluoroamphetamine in Schedule I](https://ontology.bommaritollc.com/id/01a110b4-43d7-7037-8c3c-4e7ac7af4229)
  - [FR Doc. 2025-10372: Schedules of Controlled Substances: Placement of Three Specific Fentanyl-Related Substances in Schedule I](https://ontology.bommaritollc.com/id/01a110b4-4a37-7003-9cd7-08e704277938)
  - [FR Doc. 2025-10503: Schedules of Controlled Substances: Placement of 3-Methoxyphencyclidine (1-\[1-(3-methoxyphenyl)cyclohexyl\]piperidine) in Schedule I](https://ontology.bommaritollc.com/id/01a110b4-4a39-7547-9f31-e54373a9bb32)
  - [FR Doc. 2025-11462: Schedules of Controlled Substances: Temporary Placement of Seven Benzimidazole-Opioids in Schedule I](https://ontology.bommaritollc.com/id/01a110b4-5fba-7639-8d9e-d852a68a5c84)
  - [FR Doc. 2025-14022: Schedules of Controlled Substances: Placement of Clonazolam, Diclazepam, Etizolam, Flualprazolam, and Flubromazolam in Schedule I of the Controlled Substances Act](https://ontology.bommaritollc.com/id/01a110b4-880c-7729-b57f-50d24c16571f)
  - [FR Doc. 2025-19348: Schedules of Controlled Substances: Placement of MDMB-4en-PINACA in Schedule I](https://ontology.bommaritollc.com/id/01a110b4-c4a6-7554-b482-87886ffdad70)
  - [FR Doc. 2025-22495: Schedules of Controlled Substances: Placement of CUMYL-PEGACLONE in Schedule I](https://ontology.bommaritollc.com/id/01a110b4-df97-7532-b92e-9388ec3117d8)
  - [FR Doc. 2025-22763: Schedules of Controlled Substances: Temporary Placement of Bromazolam in Schedule I](https://ontology.bommaritollc.com/id/01a110b4-e060-7585-8e02-0ea15320384a)
  - [FR Doc. 2025-22963: Schedules of Controlled Substances: Placement of 4F-MDMB-BUTICA, ADB-4en-PINACA, 5F-EDMB-PICA, and MMB-FUBICA in Schedule I](https://ontology.bommaritollc.com/id/01a110b4-e1f1-739a-8e60-1bd51d7684c1)
  - [FR Doc. 2026-00954: Schedules of Controlled Substances: Temporary Placement of 2-Fluorodeschloroketamine in Schedule I](https://ontology.bommaritollc.com/id/01a110b4-f4ed-717c-9b4a-f3460f94aadc)
  - [FR Doc. 2026-10379: Schedules of Controlled Substances; Removal of Exemption Status for Inactive Butalbital Products](https://ontology.bommaritollc.com/id/01a110b5-41bc-7272-b156-b70a69f10b87)
  - [FR Doc. 2026-10380: Schedules of Controlled Substances: Placement of Diphenidine in Schedule I](https://ontology.bommaritollc.com/id/01a110b5-41ba-726d-a0b2-2f7719c38127)
  - [FR Doc. 2026-13364: Schedules of Controlled Substances: Temporary Placement of 5,6- Dichloro Brorphine, 5,6-Dichloro Desmethylchlorphine, N-Propionitrile Chlorphine, and Spirochlorphine in Schedule I of the Controlled Substances Act](https://ontology.bommaritollc.com/id/01a110b5-5e38-7501-a84c-95c5a6c98cba)
  - [FR Doc. 2026-13580: Schedules of Controlled Substance: Temporary Placement of 7-Hydroxymitragynine Above a Specified Threshold in Schedule I](https://ontology.bommaritollc.com/id/01a110b5-60f8-7227-bdf8-50123fab2b06)
  - [FR Doc. 2026-13581: Schedules of Controlled Substances: Temporary Placement of Mitragynine Pseudoindoxyl, MGM-15, and MGM-16 in Schedule I](https://ontology.bommaritollc.com/id/01a110b5-60f7-73c0-a84e-8d6077da27ca)
  - [FR Doc. 2026-13821: Schedules of Controlled Substances: Placement of Tianeptine in Schedule I](https://ontology.bommaritollc.com/id/01a110b5-630c-7437-8b45-0990dd88b09f)
  - [FR Doc. 2026-16375: Schedules of Controlled Substances: Rescheduling of Suvorexant, Lemborexant, and Daridorexant From Schedule IV Into Schedule V](https://ontology.bommaritollc.com/id/01a110b5-7ba9-750a-84ac-e449e3e49706)
  - [FR Doc. 2026-19400: Schedules of Controlled Substances: Placement of 4-Hydroxy-N,N-Diisopropyltryptamine (4-OH-DiPT), 5-Methoxy-alpha-Methyltryptamine (5-MeO-AMT), 5-Methoxy-N-Methyl-N-Isopropyltryptamine (5-MeO-MiPT), 5-Methoxy-N,N-Diethyltryptamine (5-MeO-DET), and N,N-Diisopropyltryptamine (DiPT) Into Schedule I](https://ontology.bommaritollc.com/id/01a110b5-9928-7191-8da5-b4aa6d1ef0fa)
- Its changes, from (48; `eli:changes`):
  - [FR Doc. 2023-04364: Schedules of Controlled Substances: Placement of Brorphine in Schedule I](https://ontology.bommaritollc.com/id/01a110b2-21a1-7315-b320-7cf85053a024)
  - [FR Doc. 2023-07335: Specific Listing for Eutylone, a Currently Controlled Schedule I Substance](https://ontology.bommaritollc.com/id/01a110b2-4493-74a2-ac11-1503bd1f2027)
  - [FR Doc. 2023-15249: Schedules of Controlled Substances: Placement of Brorphine in Schedule I; Correction](https://ontology.bommaritollc.com/id/01a110b2-98f2-74c0-b001-82d59ae56808)
  - [FR Doc. 2023-15747: Implementation of the Designer Anabolic Steroid Control Act of 2014](https://ontology.bommaritollc.com/id/01a110b2-a361-760c-9917-1796e0f1bab8)
  - [FR Doc. 2023-15748: Schedules of Controlled Substances: Temporary Placement of Etizolam, Flualprazolam, Clonazolam, Flubromazolam, and Diclazepam in Schedule I](https://ontology.bommaritollc.com/id/01a110b2-9e12-737b-820a-63cb3373c94f)
  - [FR Doc. 2023-17778: Schedules of Controlled Substances: Placement of Metonitazene in Schedule I](https://ontology.bommaritollc.com/id/01a110b2-b26d-7331-93b7-649340c9088c)
  - [FR Doc. 2023-23982: Schedules of Controlled Substances: Placement of Zuranolone in Schedule IV](https://ontology.bommaritollc.com/id/01a110b2-ea30-7747-9de6-11d8d5185ac6)
  - [FR Doc. 2023-26694: Schedules of Controlled Substances: Placement of Nine Specific Fentanyl-Related Substances in Schedule I](https://ontology.bommaritollc.com/id/01a110b3-01ab-7490-8f60-2fa111a21e38)
  - [FR Doc. 2023-27243: Schedules of Controlled Substances: Temporary Placement of MDMB-4en-PINACA, 4F-MDMB-BUTICA, ADB-4en-PINACA, CUMYL-PEGACLONE, 5F-EDMB-PICA, and MMB-FUBICA into Schedule I](https://ontology.bommaritollc.com/id/01a110b3-0477-75d7-b213-b04c3137b28b)
  - [FR Doc. 2023-27292: Specific Listing for Three Currently Controlled Schedule I Substances](https://ontology.bommaritollc.com/id/01a110b3-0588-7004-94a9-e13c922c634b)
  - [FR Doc. 2024-05543: Schedules of Controlled Substances: Placement of 2-Methyl AP-237 in Schedule I](https://ontology.bommaritollc.com/id/01a110b3-3c2b-7370-9af0-dd287966442e)
  - [FR Doc. 2024-07684: Schedules of Controlled Substances: Placement of Etodesnitazene, N-Pyrrolidino Etonitazene, and Protonitazene in Schedule I](https://ontology.bommaritollc.com/id/01a110b3-4ba6-7752-8bec-6def8d58a954)
  - [FR Doc. 2024-07689: Schedules of Controlled Substances: Extension of Temporary Placement of Butonitazene, Flunitazene, and Metodesnitazene in Schedule I of the Controlled Substances Act](https://ontology.bommaritollc.com/id/01a110b3-4ba8-73ec-8b24-ce4fe7e7879f)
  - [FR Doc. 2024-16391: Schedules of Controlled Substances: Temporary Placement of N-Desethyl Isotonitazene and N-Piperidinyl Etonitazene in Schedule I](https://ontology.bommaritollc.com/id/01a110b3-88f2-7688-b0b8-f1a42dd95841)
  - [FR Doc. 2024-18087: Schedules of Controlled Substances: Placement of Zuranolone in Schedule IV](https://ontology.bommaritollc.com/id/01a110b3-9301-7766-b890-456a0464f3c1)
  - [FR Doc. 2024-24083: Schedules of Controlled Substances: Placement of Ethylphenidate in Schedule I](https://ontology.bommaritollc.com/id/01a110b3-bc53-72e5-9939-587dfe31d029)
  - [FR Doc. 2024-24635: Schedules of Controlled Substances: Placement of Butonitazene, Flunitazene, and Metodesnitazene Substances in Schedule I](https://ontology.bommaritollc.com/id/01a110b3-bf16-75c1-b889-9de106f6c715)
  - [FR Doc. 2024-31130: Schedules of Controlled Substances: Extension of Temporary Placement of Seven Specific Fentanyl-Related Substances in Schedule I of the Controlled Substances Act](https://ontology.bommaritollc.com/id/01a110b3-e61d-7575-a1e2-455d2ca3600f)
  - [FR Doc. 2025-09989: Schedules of Controlled Substances: Placement of 2-Methyl AP-237 in Schedule I; Correction](https://ontology.bommaritollc.com/id/01a110b4-43ae-7149-bffb-8a3f7d95e9fb)
  - [FR Doc. 2025-14037: Schedules of Controlled Substances: Extension of Temporary Placement of Clonazolam, Diclazepam, Etizolam, Flualprazolam, and Flubromazolam in Schedule I of the Controlled Substances Act](https://ontology.bommaritollc.com/id/01a110b4-8805-7027-a333-2d6df7287e82)
  - [FR Doc. 2025-15177: Specific Listing for Dipentylone, a Currently Controlled Schedule I Substance](https://ontology.bommaritollc.com/id/01a110b4-97e8-72a8-b819-0fb65d3dbdaf)
  - [FR Doc. 2025-15566: Schedules of Controlled Substances: Temporary Placement of N-pyrrolidino metonitazene and N-pyrrolidino protonitazene in Schedule I](https://ontology.bommaritollc.com/id/01a110b4-9f94-75e6-9e5f-17108ad31330)
  - [FR Doc. 2025-18103: Schedules of Controlled Substances: Placement of Seven Specific Fentanyl-Related Substances in Schedule I](https://ontology.bommaritollc.com/id/01a110b4-ba77-74bb-b13d-30f8bb5e06b8)
  - [FR Doc. 2025-19542: Schedules of Controlled Substances: Temporary Placement of Ethyleneoxynitazene, Methylenedioxynitazene, 5-Methyl Etodesnitazene, N-Desethyl Etonitazene, N-Desethyl Protonitazene, N,N-Dimethylamino Etonitazene, and N-Pyrrolidino Isotonitazene in Schedule I](https://ontology.bommaritollc.com/id/01a110b4-c6fd-75d4-995e-fa87ab1b7f02)
  - [FR Doc. 2025-20004: Schedules of Controlled Substances: Placement of 4-Chloromethcathinone in Schedule I](https://ontology.bommaritollc.com/id/01a110b4-c94c-74d4-a9ec-18ea38a964d0)
  - [FR Doc. 2025-22496: Schedules of Controlled Substances: Extension of Temporary Placement of CUMYL-PEGACLONE in Schedule I of the Controlled Substances Act](https://ontology.bommaritollc.com/id/01a110b4-df9a-71ee-872b-68133186c88d)
  - [FR Doc. 2025-22540: Schedules of Controlled Substances: Extension of Temporary Placement of MDMB-4en-PINACA in Schedule I of the Controlled Substances Act](https://ontology.bommaritollc.com/id/01a110b4-deed-77ae-bbc4-042c718816ba)
  - [FR Doc. 2025-22960: Schedules of Controlled Substances: Extension of Temporary Placement of 4F-MDMB-BUTICA, ADB-4en-PINACA, 5F-EDMB-PICA, and MMB-FUBICA in Schedule I of the Controlled Substances Act](https://ontology.bommaritollc.com/id/01a110b4-e1db-708f-a18d-f4c60ae8051f)
  - [FR Doc. 2025-23717: Schedules of Controlled Substances: Placement of N-Desethyl Isotonitazene and N-Piperidinyl Etonitazene in Schedule I](https://ontology.bommaritollc.com/id/01a110b4-e7d0-7150-8ead-f0b8570fe325)
  - [FR Doc. 2026-00362: Schedules of Controlled Substances: Placement of N-Pyrrolidino Metonitazene and N-Pyrrolidino Protonitazene in Schedule I](https://ontology.bommaritollc.com/id/01a110b4-efc0-7391-8771-0efef802db12)
  - [FR Doc. 2026-00633: Schedules of Controlled Substances: Placement of 4-Fluoroamphetamine in Schedule I](https://ontology.bommaritollc.com/id/01a110b4-f254-71f7-bc26-53a7bba0b9f0)
  - [FR Doc. 2026-00907: Definition of “Cannabimimetic Agents” and Assignment of an Administration Controlled Substances Code Number for All “Cannabimimetic Agents”](https://ontology.bommaritollc.com/id/01a110b4-f4d1-7392-a2d1-c6b634d245ca)
  - [FR Doc. 2026-04112: Schedules of Controlled Substances: Placement of Clonazolam, Diclazepam, Etizolam, Flualprazolam, and Flubromazolam in Schedule I of the Controlled Substances Act](https://ontology.bommaritollc.com/id/01a110b5-0ddc-7793-9ef6-7c60040e947a)
  - [FR Doc. 2026-05064: Schedules of Controlled Substances: Temporary Placement of Bromazolam in Schedule I](https://ontology.bommaritollc.com/id/01a110b5-1504-75ab-8766-e1ee16f24a2b)
  - [FR Doc. 2026-05618: Schedules of Controlled Substances: Placement of 3-Methoxyphencyclidine (1-(1-(3-Methoxyphenyl)cyclohexyl)piperidine) in Schedule I](https://ontology.bommaritollc.com/id/01a110b5-1969-77c7-8d8b-1295408ced52)
  - [FR Doc. 2026-08104: Schedules of Controlled Substances: Placement of MDMB-4en-PINACA in Schedule I](https://ontology.bommaritollc.com/id/01a110b5-2c48-710a-a955-882068ba0320)
  - [FR Doc. 2026-08176: Schedules of Controlled Substances: Rescheduling of Food and Drug Administration Approved Products Containing Marijuana From Schedule I to Schedule III; Corresponding Change to Permit Requirements](https://ontology.bommaritollc.com/id/01a110b5-2e19-7110-b339-84dbbd8768a5)
  - [FR Doc. 2026-08517: Schedules of Controlled Substances: Placement of 4F-MDMB-BUTICA, ADB-4en-PINACA, 5F-EDMB-PICA, and MMB-FUBICA in Schedule I](https://ontology.bommaritollc.com/id/01a110b5-3006-7219-8192-c7d474bb9cbc)
  - [FR Doc. 2026-08595: Specific Listing for Hexahydrocannabinol, A Currently Controlled Schedule I Substance](https://ontology.bommaritollc.com/id/01a110b5-3087-73cb-adc2-98cdb6403908)
  - [FR Doc. 2026-09566: Schedules of Controlled Substances: Placement of CUMYL-PEGACLONE in Schedule I](https://ontology.bommaritollc.com/id/01a110b5-38d8-772f-ae64-16565632c5fa)
  - [FR Doc. 2026-10253: Schedules of Controlled Substances: Temporary Placement of 2-Fluorodeschloroketamine in Schedule I](https://ontology.bommaritollc.com/id/01a110b5-4052-70df-a72f-1b25115ca01d)
  - [FR Doc. 2026-12653: Schedules of Controlled Substances: Placement of Bromazolam in Schedule I; Correction](https://ontology.bommaritollc.com/id/01a110b5-5768-765e-89bf-8000b97ce9ed)
  - [FR Doc. 2026-12654: Schedules of Controlled Substances: Temporary Placement of O-Desmethyltramadol in Schedule I](https://ontology.bommaritollc.com/id/01a110b5-576f-7236-9c73-8fc8945c04d5)
  - [FR Doc. 2026-16413: Schedules of Controlled Substances: Temporary Placement of O-Desmethyltramadol in Schedule I](https://ontology.bommaritollc.com/id/01a110b5-7cfa-7210-94b0-815a489a6025)
  - [FR Doc. 2026-17429: Schedules of Controlled Substances: Temporary Placement of Mitragynine Pseudoindoxyl, MGM-15, and MGM-16 in Schedule I](https://ontology.bommaritollc.com/id/01a110b5-8639-732b-ba0e-d31bd14201a4)
  - [FR Doc. 2026-17531: Schedules of Controlled Substances: Temporary Placement of 5,6-Dichloro Brorphine, 5,6-Dichloro Desmethylchlorphine, N-Propionitrile Chlorphine, and Spirochlorphine in Schedule I of the Controlled Substances Act](https://ontology.bommaritollc.com/id/01a110b5-874b-749c-a4b6-74d53d413316)
  - [FR Doc. 2026-17536: Schedules of Controlled Substances: Placement of Cipepofol in Schedule IV](https://ontology.bommaritollc.com/id/01a110b5-874c-779a-873c-aa14e596a9a3)
  - [FR Doc. 2026-19231: Schedules of Controlled Substances: Placement of Diphenidine in Schedule I](https://ontology.bommaritollc.com/id/01a110b5-96bc-7440-ab82-b766f88828f4)
- Parts (9; `schema:isPartOf`):
  - [21 CFR Part 1308, Subject Group: Excluded Nonnarcotic Substances—Excluded Nonnarcotic Substances](https://ontology.bommaritollc.com/id/01a0f094-b78b-70be-8a34-20573e26f315)
  - [21 CFR Part 1308, Subject Group: Excluded Veterinary Anabolic Steroid Implant Products—Excluded Veterinary Anabolic Steroid Implant Products](https://ontology.bommaritollc.com/id/01a0f094-b78d-75c8-a808-2ad1a095348d)
  - [21 CFR Part 1308, Subject Group: Exempt Anabolic Steroid Products—Exempt Anabolic Steroid Products](https://ontology.bommaritollc.com/id/01a0f094-b78e-73a7-8187-e3c5b265f766)
  - [21 CFR Part 1308, Subject Group: Exempt Cannabis Plant Material, and Products Made Therefrom, that Contain Tetrahydrocannabinols—Exempt Cannabis Plant Material, and Products Made Therefrom, that Contain Tetrahydrocannabinols](https://ontology.bommaritollc.com/id/01a0f094-b78f-77b2-99f3-f665f788f5b8)
  - [21 CFR Part 1308, Subject Group: Exempt Chemical Preparations—Exempt Chemical Preparations](https://ontology.bommaritollc.com/id/01a0f094-b78c-7104-9ce7-e877298f04c1)
  - [21 CFR Part 1308, Subject Group: Exempted Prescription Products—Exempted Prescription Products](https://ontology.bommaritollc.com/id/01a0f094-b78e-73a7-8187-e3b86cfa2749)
  - [21 CFR Part 1308, Subject Group: General Information—General Information](https://ontology.bommaritollc.com/id/01a0f094-b78a-7281-9606-8039898a8fcd)
  - [21 CFR Part 1308, Subject Group: Hearings—Hearings](https://ontology.bommaritollc.com/id/01a0f094-b790-7589-866e-5b3f4cb6d26d)
  - [21 CFR Part 1308, Subject Group: Schedules—Schedules](https://ontology.bommaritollc.com/id/01a0f094-b78b-70be-8a34-204bdd246884)

---
Also as: [Turtle](https://ontology.bommaritollc.com/id/01a0f094-b8cd-732f-a957-b60db5d17f2b.ttl), [JSON-LD](https://ontology.bommaritollc.com/id/01a0f094-b8cd-732f-a957-b60db5d17f2b.jsonld), [N-Triples](https://ontology.bommaritollc.com/id/01a0f094-b8cd-732f-a957-b60db5d17f2b.nt), [HTML](https://ontology.bommaritollc.com/id/01a0f094-b8cd-732f-a957-b60db5d17f2b)
Cite as: 21 CFR Part 1308—Schedules of controlled substances. bc-ontology, release 0.1.0-rc38, 2026-10-21. https://ontology.bommaritollc.com/id/01a0f094-b8cd-732f-a957-b60db5d17f2b
Release 0.1.0-rc38, graph hash 05350a11cf9d0c42fba51e92b877115781ab65cb92afcd6b172ff9f8f4abf0bd.
